Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors.

Saleh, Nashwa M; El-Gazzar, Marwa G; Aly, Hala M; Othman, Rana A

Saleh, Nashwa M; El-Gazzar, Marwa G; Aly, Hala M; Othman, Rana A.

Afiliación

Saleh NM; Department of Chemistry, Faculty of Science (Girl's), Al-Azhar University, Cairo, Egypt.
El-Gazzar MG; Department of Drug Radiation Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
Aly HM; Department of Chemistry, Faculty of Science (Girl's), Al-Azhar University, Cairo, Egypt.
Othman RA; Department of Chemistry, Faculty of Science (Girl's), Al-Azhar University, Cairo, Egypt.

Front Chem ; 7: 917, 2019.

Article en En | MEDLINE | ID: mdl-32039146

Palabras clave

EGFR; HEPG2; VEGFR-2; anticancer; fused pyrazoles

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Chem Año: 2019 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google